Qiuxiang Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qiuxiang Tan has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Beili Wu
State Key Laboratory of Drug Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
6 shared publications - Qiang Zhao
State Key Laboratory of Drug Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203
6 shared publications Cuiying Yi
State Key laboratory of Drug, Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
3 shared publicationsLimin Ma
State Key laboratory of Drug, Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
3 shared publicationsMu Wang
State Key laboratory of Drug, Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
3 shared publications- Shuo Han
CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 20 April 2026
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 33 (4) , 691-700
Ligand binding modes of the bitter taste receptor T2R14 and T2R46
Bitter taste receptors (T2Rs) are considered attractive drug targets. However, the ligand recognition and selectivity of these receptors remain elusive, hampering their drug development. Here we present seven structures of human T2R14 and T2R46 in apo or ligand-bound state. Combined with molecular docking and mutagenesis data, the structures reveal an extracellular ligand-binding site in T2R14 for most of its ligands, which is different from the intracellular binding site reported recently. In contrast, T2R46 exhibits a conserved binding pocket that accommodates various ligands with distinct interaction patterns. Furthermore, the second extracellular loop in T2R14 and T2R46 acts as a tethered agonist to potentially facilitate agonist response of these two receptors to the weak tastant agonists. These findings could accelerate drug discovery targeting T2Rs.
- 20 April 2026
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 33 (4) , 691-700
Open AccessLigand binding modes of the bitter taste receptor T2R14 and T2R46
Bitter taste receptors (T2Rs) are considered attractive drug targets. However, the ligand recognition and selectivity of these receptors remain elusive, hampering their drug development. Here we present seven structures of human T2R14 and T2R46 in apo or ligand-bound state. Combined with molecular docking and mutagenesis data, the structures reveal an extracellular ligand-binding site in T2R14 for most of its ligands, which is different from the intracellular binding site reported recently. In contrast, T2R46 exhibits a conserved binding pocket that accommodates various ligands with distinct interaction patterns. Furthermore, the second extracellular loop in T2R14 and T2R46 acts as a tethered agonist to potentially facilitate agonist response of these two receptors to the weak tastant agonists. These findings could accelerate drug discovery targeting T2Rs.
- Open Access
- 20 August 2025
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 17 (7) , 662-668
Structural basis of allosteric and bitopic ligands binding in sphingosine-1-phosphate receptors 2 and 3
- 20 August 2025
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 17 (7) , 662-668
Open AccessStructural basis of allosteric and bitopic ligands binding in sphingosine-1-phosphate receptors 2 and 3
- Open Access
- 15 July 2022
- Published by Springer Nature in Protein & Cell
- Vol. 14 (5) , 382-386
Structural insights into signal transduction of the purinergic receptors P2Y1R and P2Y12R
Dear Editor,
- 15 July 2022
- Published by Springer Nature in Protein & Cell
- Vol. 14 (5) , 382-386
Open AccessStructural insights into signal transduction of the purinergic receptors P2Y1R and P2Y12R
Dear Editor,
- Open Access
- 1 July 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (26) , eabn8048
Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
As the only member of the CX3C chemokine receptor subfamily, CX3CR1 binds to its sole endogenous ligand CX3CL1, which shows notable potential as a therapeutic target in atherosclerosis, cancer, and neuropathy. However, the drug development of CX3CR1 is hampered partially by the lack of structural information. Here, we present two cryo–electron microscopy structures of CX3CR1-G i1 complexes in ligand-free and CX3CL1-bound states at 2.8- and 3.4-Å resolution, respectively. Together with functional data, the structures reveal the key factors that govern the recognition of CX3CL1 by both CX3CR1 and US28. A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-G i complex structures is observed in CX3CR1, which may correlate with three cholesterol molecules that play essential roles in conformation stabilization and signaling transduction. Thus, our data deepen the understanding of cholesterol modulation in GPCR (G protein–coupled receptor) signaling and provide insights into the diversity of G protein coupling.
- 1 July 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (26) , eabn8048
Open AccessActivation of the human chemokine receptor CX3CR1 regulated by cholesterol
As the only member of the CX3C chemokine receptor subfamily, CX3CR1 binds to its sole endogenous ligand CX3CL1, which shows notable potential as a therapeutic target in atherosclerosis, cancer, and neuropathy. However, the drug development of CX3CR1 is hampered partially by the lack of structural information. Here, we present two cryo–electron microscopy structures of CX3CR1-G i1 complexes in ligand-free and CX3CL1-bound states at 2.8- and 3.4-Å resolution, respectively. Together with functional data, the structures reveal the key factors that govern the recognition of CX3CL1 by both CX3CR1 and US28. A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-G i complex structures is observed in CX3CR1, which may correlate with three cholesterol molecules that play essential roles in conformation stabilization and signaling transduction. Thus, our data deepen the understanding of cholesterol modulation in GPCR (G protein–coupled receptor) signaling and provide insights into the diversity of G protein coupling.
- Open Access
- 6 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (18) , eabm1232
Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors
In response to three highly conserved neuropeptides, neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP), four G protein–coupled receptors mediate multiple essential physiological processes, such as food intake, vasoconstriction, sedation, and memory retention. Here, we report the structures of the human Y 1 , Y 2 , and Y 4 receptors in complex with NPY or PP, and the G i1 protein. These structures reveal distinct binding poses of the peptide upon coupling to different receptors, reflecting the importance of the conformational plasticity of the peptide in recognizing the NPY receptors. The N terminus of the peptide forms extensive interactions with the Y 1 receptor, but not with the Y 2 and Y 4 receptors. Supported by mutagenesis and functional studies, subtype-specific interactions between the receptors and peptides were further observed. These findings provide insight into key factors that govern NPY signal recognition and transduction, and would enable development of selective drugs.
- 6 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (18) , eabm1232
Open AccessReceptor-specific recognition of NPY peptides revealed by structures of NPY receptors
In response to three highly conserved neuropeptides, neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP), four G protein–coupled receptors mediate multiple essential physiological processes, such as food intake, vasoconstriction, sedation, and memory retention. Here, we report the structures of the human Y 1 , Y 2 , and Y 4 receptors in complex with NPY or PP, and the G i1 protein. These structures reveal distinct binding poses of the peptide upon coupling to different receptors, reflecting the importance of the conformational plasticity of the peptide in recognizing the NPY receptors. The N terminus of the peptide forms extensive interactions with the Y 1 receptor, but not with the Y 2 and Y 4 receptors. Supported by mutagenesis and functional studies, subtype-specific interactions between the receptors and peptides were further observed. These findings provide insight into key factors that govern NPY signal recognition and transduction, and would enable development of selective drugs.
- Top Cited Papers
- 20 March 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 367 (6484) , 1346-1352
Structural basis of G s and G i recognition by the human glucagon receptor
Choosing a partner that fits: G protein–coupled receptors (GPCRs) are responsible for transducing diverse signals from outside to inside cells. This process requires specificity both in ligand binding to GPCRs and in coupling between GPCRs and their intracellular partners, G proteins. Qiao et al. determined the structure of the human glucagon receptor (GCGR), a type B GPCR, bound to glucagon and one of two heterotrimeric G proteins, G s or G i1 . GCGR signals mainly through G s , and the structures provide a basis for this specificity. Conformational changes in GCGR, relative to the inactive state, create a binding cavity for the G proteins. The pocket is opened sufficiently to accommodate a bulky binding motif in G s . G i1 can still bind but the pocket does not close around it, so there is a smaller interaction interface. Science , this issue p. 1346
- 20 March 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 367 (6484) , 1346-1352
Top Cited PapersStructural basis of G s and G i recognition by the human glucagon receptor
Choosing a partner that fits: G protein–coupled receptors (GPCRs) are responsible for transducing diverse signals from outside to inside cells. This process requires specificity both in ligand binding to GPCRs and in coupling between GPCRs and their intracellular partners, G proteins. Qiao et al. determined the structure of the human glucagon receptor (GCGR), a type B GPCR, bound to glucagon and one of two heterotrimeric G proteins, G s or G i1 . GCGR signals mainly through G s , and the structures provide a basis for this specificity. Conformational changes in GCGR, relative to the inactive state, create a binding cavity for the G proteins. The pocket is opened sufficiently to accommodate a bulky binding motif in G s . G i1 can still bind but the pocket does not close around it, so there is a smaller interaction interface. Science , this issue p. 1346